Survey Reveals ‘Striking’ Barriers to Accessing High-Priority Cancer Drugs
Respondents said some essential cancer drugs had substantial out-of-pocket costs, and some posed a high risk of catastrophic expenditure.
Respondents said some essential cancer drugs had substantial out-of-pocket costs, and some posed a high risk of catastrophic expenditure.
For patients hospitalized with COVID-19, prostate cancer was the most common cancer type across all databases.
The AACR COVID-19 and Cancer Task Force recommends keeping changes to clinical trial practices that were prompted by the pandemic.
A statement recommends including cancer patients and survivors in COVID-19 vaccine trials.
GRASP co-founder Julia Maués explains how the initiative came about and reveals plans for the future.
There was a significant improvement in progression-free survival with bevacizumab, but it was not considered clinically meaningful.
New guidelines recommend using the full approved doses of immunotherapy and targeted therapies for patients with cancer and obesity.
A decrease in obesity rates may reduce the burden of gallbladder and biliary tract cancer worldwide, according to the results of a study.